Medical device makers should be aware of how FDA decides to regulate wound dressings containing drugs, since that regulation is likely to be broadly applied to all devices containing antimicrobial ...
The powerful antimicrobial teixobactin was discovered using a new technique that could speed up the discovery of new antibiotics to tackle resistance ...
LABT READ THE FULL LABT RESEARCH REPORT We are initiating coverage of Lakewood-Amedex Biotherapeutics, Inc. (NASDAQ: LABT) with a valuation of $12.00. Lakewood-Amedex is a clinical-stage ...
A Vauxhall biotechnology company has discovered eight new classes of infection-fighting antimicrobial agents since 2025 – ...
Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT, the "Company"), a clinical-stage biotechnology company advancing a novel ...
Through trend analyses, this surveillance highlighted both the emergence and decline of AMR across diverse bacterial pathogens, helping inform which antibiotics may remain appropriate as first-line ...
Introduction Antimicrobial stewardship efforts in low- and middle-income countries (LMICs) largely focus on qualified ...
Hyderabad: At a time when antimicrobial resistance (AMR) is emerging as a major public health concern, nearly three out of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results